Affiliation: University of North Carolina at Charlotte

Dr. Andrew W. Truman is a British-American Biochemist and Cancer Biologist. Dr. Truman completed postdoctoral studies at Johns Hopkins Bloomberg School of Public Health and at Boston University. He joined the laboratory of Dr. Stephen Kron at the University of Chicago as a Research Professional Associate in 2010. In 2015, he joined the Department of Biological Sciences at UNC Charlotte and in 2021 was promoted to Associate Professor with Tenure.

He is a Senior Editor for the journal Cell Stress and Chaperones and a Review Editor for Frontiers in Molecular Biosciences. He became a fellow of the Cell Stress Society International (FSSI) in 2020. Dr. Truman is recognized for his research on the interplay of molecular chaperones and signal transduction pathways. In particular, he has been a major proponent of the idea of the “Chaperone Code”, the combination of post-translational modifications that regulate chaperone function. Dr. Truman’s laboratory has discovered a reliance of the important ribonucleotide reductase complex on molecular chaperones. This work has led to other studies examining synergy between drugs that inhibit RNR and chaperones in cancer.

His research team has been supported by grants from the National Institute of General Medical Sciences and National Cancer Institute to explore the connection between chaperones and the cellular response to DNA damage.